Loading clinical trials...
Loading clinical trials...
LMY-920 for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma
Conditions
Interventions
BAFF CAR-T
Locations
2
United States
University Hospitals Seidman Cancer Center
Cleveland, Ohio, United States
Taussig Cancer Institute | Cleveland Clinic
Cleveland, Ohio, United States
Start Date
November 21, 2023
Primary Completion Date
May 1, 2025
Completion Date
September 2, 2025
Last Updated
October 21, 2024
Lead Sponsor
Luminary Therapeutics
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions